Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
Hartmut LinkG IllerhausU M MartensA SalarR DepenbuschA KöhlerM EngelhardtS MahlmannM ZaissA LammerichP BiasA BuchnerPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
ClinicalTrials.gov identifier NCT02044276; EudraCT number 2013-001284-23.